Synthesis, molecular modelling and QSAR study of new N-phenylacetamide-2-oxoindole benzensulfonamide conjugates as carbonic anhydrase inhibitors with antiproliferative activity

References

• Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
   PubMed Web of Science ®Google Scholar
• Boone CD, Pinard M, McKenna R, Silverman D. Catalytic mechanism of α-class carbonic anhydrases: CO2 hydration and proton transfer. Subcell Biochem 2014;75:31–52.
   PubMedGoogle Scholar
• McKenna R, Supuran CT. Carbonic anhydrase inhibitors drug design. Subcell Biochem 2014;75:291–323.
   PubMedGoogle Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72.
   PubMed Web of Science ®Google Scholar
• Luca LD, Mancuso F, Ferro S, et al. Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases. Eur J Med Chem 2018;143:276–82.
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77.
   PubMed Web of Science ®Google Scholar
• Awadallah FM, El-Waei TA, Hanna MM, et al. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives. Eur J Med Chem 2015;96:425–35.
   PubMed Web of Science ®Google Scholar
• Awadallah FM, Bua S, Mahmoud WR, et al. Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails. J Enzyme Inhib Med Chem 2018;33:629–38.
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Alsaid MS, Soliman AM, Al-Mishari AA. Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors. J Enzyme Inhib Med Chem 2018;33:67–73.
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Alsaid MS, Soliman AM, Ragab FA. VEGFR-2 inhibitors and apoptosis inducers: synthesis and molecular design of new benzo[g]quinazolin bearing benzenesulfonamide moiety. J Enzyme Inhib Med Chem 2017;32:893–907.
   PubMed Web of Science ®Google Scholar
• Mboge MY, McKenna R, Frost SC. Advances in anti-cancer drug development targeting carbonic anhydrase IX and XII. Top Anti-Cancer Res 2015;5:3–42.
   PubMedGoogle Scholar
• Supuran CT. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2018;27:963–70.
   PubMed Web of Science ®Google Scholar
• Krasavin M, Korsakov M, Dorogov M, et al. Probing the 'bipolar' nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms. Eur J Med Chem 2015;101:334–3478.
   PubMed Web of Science ®Google Scholar
• Ibrahim HS, Allam HA, Mahmoud WR, et al. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform. Eur J Med Chem 2018;152:1–9.
   PubMed Web of Science ®Google Scholar
• Chiaramonte N, Romanelli MN, Teodori E, Supuran CT. Amino acids as building blocks for carbonic anhydrase inhibitors. Metabolites 2018;8:36–57.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. Curr Pharm Des 2008;14:641–8.
   PubMed Web of Science ®Google Scholar
• Borras J, Scozzafava A, Menabuoni L, et al. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring? Bioorg Med Chem 1999;7:2397–406.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Acetazolamide for the treatment of idiopathic intracranial hypertension. Expert Rev Neurother 2015;15:851–6.
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Soliman AM, Alsaid MS, Askar AA. Synthesis, antimicrobial activity and docking study of some novel 4-(4, 4-dimethyl-2, 6- dioxocyclohexylidene) methylamino derivatives carrying biologically active sulfonamide moiety. Arab J Chem 2020;13:545–56.
   Web of Science ®Google Scholar
• Borne RF, Peden RL, Waters I, et al. Anti-inflammatory activity of para-substituted N-benzenesulfonyl derivatives of anthranilic acid. J Pharm Sci 1974;63:615–7.
   PubMed Web of Science ®Google Scholar
• Soliman AM, Karam HM, Mekkawy MH, Ghorab MM. Antioxidant activity of novel quinazolinones bearing sulfonamide: potential radiomodulatory effects on liver tissues via NF-kB/PON1 pathway. Eur J Med Chem 2020;197:112333.
   PubMed Web of Science ®Google Scholar
• Soliman AM, Alqahtani AS, Ghorab M. Novel sulphonamide benzoquinazolinones as dual EGFR/HER2 inhibitors, apoptosis inducers and radiosensitizers. J Enzyme Inhib Med Chem 2019;34:1030–40.
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Alsaid MS, El-Gaby MS, et al. Biological evaluation of some new N-(2,6-dimethoxypyrimidinyl) thioureido benzenesulfonamide derivatives as potential antimicrobial and anticancer agents. Eur J Med Chem 2016;124:299–310.
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Ragab FA, Heiba HI, Soliman AM. Anticancer and radiosensitizing evaluation of some new sulfonamide derivatives bearing pyridone, thiophene, and hydrazone moieties. Res Chem Intermed 2017;43:4657–81.
   Web of Science ®Google Scholar
• Chow LQ, Eckhardt SG. Sunitinib: from rational design to clinical efficacy. J Clin Oncol 2007;25:884–96.
   PubMed Web of Science ®Google Scholar
• Abo-Ashour MF, Eldehna WM, Nocentini A, et al. Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies. Eur J Med Chem 2018;157:28–36.
   PubMed Web of Science ®Google Scholar
• Abo-Ashour MF, Eldehna WM, Nocentini A, et al. 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights. Eur J Med Chem 2019;184:111768.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Abo-Ashour MF, Nocentini A, et al. Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents. Eur J Med Chem 2019;162:147–60.
   PubMed Web of Science ®Google Scholar
• George RF, Said MF, Bua S, Supuran CT. Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII. Bioorg Chem 2020;95:103514.
   PubMed Web of Science ®Google Scholar
• George RF, Bua S, Supuran CT, Awadallah FM. Synthesis of some N-aroyl-2-oxindole benzenesulfonamide conjugates with carbonic anhydrase inhibitory activity. Bioorg Chem 2020;96:103635.
   PubMed Web of Science ®Google Scholar
• Kumar R, Kaur M, Bahia MS, Silakari O. Synthesis, cytotoxic study and docking based multidrug resistance modulator potential analysis of 2-(9-oxoacridin-10(9H)-yl)-N-phenyl acetamides. Eur J Med Chem 2014;80:83–91.
   PubMed Web of Science ®Google Scholar
• Monforte AM, Ferro S, Luca LD, et al. Design and synthesis of N1-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg Med Chem 2014;22:1459–67.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chan FY, Sun N, Lui HK, et al. Structure-based Design, Synthesis, and Biological Evaluation of Isatin Derivatives as Potential Glycosyltransferase Inhibitors. Chem Biol Drug Des 2014;84:685–96.
   PubMed Web of Science ®Google Scholar
• Akgul O, Tarikogullari AH, Kose FA, Ballar P. Synthesis and cytotoxic activity of some 2-(2,3-dioxo-2,3-dihydro-1H-indol-1-yl)acetamide derivatives. Turkish J Chem 2013;37:204–12.
   Web of Science ®Google Scholar
• Firoozpour L, Gao L, Moghimi S, et al. Efficient synthesis, biological evaluation, and docking study of isatin based derivatives as caspase inhibitors. J Enzyme Inhib Med Chem 2020;35:1674–84.
   PubMed Web of Science ®Google Scholar
• Soliman R. Preparation and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles. J Med Chem 1979;22:321–5.
   PubMed Web of Science ®Google Scholar
• Wani TV, Bua S, Khude PS, et al. Evaluation of sulphonamide derivatives acting as inhibitors of human carbonic anhydrase isoforms I, II and Mycobacterium tuberculosis β-class enzyme Rv3273. J Enzyme Inhib Med Chem 2018;33:962–71.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stopflow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Trallori E, Singh S, et al. 4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced antiproliferative profiles. J Med Chem 2018;61:10860–74.
   PubMed Web of Science ®Google Scholar
• Entezari Heravi Y, Bua S, Nocentini A, et al. Inhibition of Malassezia globosa carbonic anhydrase with phenols. Bioorg Med Chem 2017;25:2577–82.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Carta F, Tanc M, et al. Deciphering the mechanism of human carbonic anhydrases inhibition with sulfocoumarins: computational and experimental studies. Chemistry 2018;24:7840–4.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Lucidi A, Perut F, et al. α,γ-Diketocarboxylic acids and their esters act as carbonic anhydrase IX and XII selective inhibitors . ACS Med Chem Lett 2019;10:661–5.
   PubMed Web of Science ®Google Scholar
• Skehan P, Storeng R, Scudiero D, et al. 82(13):, New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107–12.
   PubMed Web of Science ®Google Scholar
• Allam RM, Al-Abd AM, Khedr A, et al. Abdel-Naim AB. Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells. Toxicol Lett 2018;291:77–85.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Fares M, Ceruso M, et al. Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII . Eur J Med Chem 2016;110:259–66.
   PubMed Web of Science ®Google Scholar
• Smirnov AS, Nikolaev DN, Gurzhiy VV, Smirnov SN, Suslonov VS, et al. Conformational stabilization of isatin Schiff bases-biologically active chemical probes. RSC Adv 2017;7:10070–3.
   Web of Science ®Google Scholar
• Chia SK, Wykoff CC, Watson PH, et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 2001;19:3660–8.
   PubMed Web of Science ®Google Scholar
• İlie M, Mazure NM, Hofman V, et al. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br J Cancer 2010;102:1627–35.
   PubMed Web of Science ®Google Scholar
• Available from: https://www.rcsb.org
   Google Scholar
• Kanamori K, Roberts JD. Nitrogen-15 nuclear magnetic resonance study of benzenesulfonamide and cyanate binding to carbonic anhydrase. Biochemistry 1983;22:2658–64.
   PubMed Web of Science ®Google Scholar
• Briganti F, Mangani S, Orioli P, et al. Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry 1997;36:10384–92.
   PubMed Web of Science ®Google Scholar
• Helland IS. On the structure of partial least squares regression. Comm Statist B, Simulation Comput 1988;17:581–607.
   Web of Science ®Google Scholar
• Geladi P, Kowalski R. Partial least squares regression: a tutorial. Analytica Chimica Acta 1986;185:1–17.
   Web of Science ®Google Scholar
• Chemopy Descriptor Calculator. http://www.scbdd.com/chemopy_desc/index/ (6/10/2021).
   Google Scholar
• Pearlman RS, Smith KM. Novel software tools for chemical diversity. Persp Drug Disc Des 1998;9:339–53.
   Google Scholar
• Gasteiger J, Marsili M. Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron 1980;36:3219–28.
   Web of Science ®Google Scholar
• Wildman SA, Crippen GM. Prediction of physiochemical parameters by atomic contributions. J Chem Inf Comput Sci 1999;39:868–73.
   Google Scholar
• Balaban AT. Five new topological indices for the branching of tree-like graphs. Theoretica Chimica Acta 1979;53:355–75.
   Google Scholar
• Gramatica P, On the Development and Validation of QSAR Models. In: Computational toxicology: Volume II, Methods in molecular biology. Reisfeld MA. Springer Science + Business Media, LLC; 2013, p. 499–526.
   Google Scholar